Asifa Habib
Examiner (ID: 14131, Phone: (571)270-7032 , Office: P/2887 )
Most Active Art Unit | 2887 |
Art Unit(s) | 2887, 2876 |
Total Applications | 354 |
Issued Applications | 240 |
Pending Applications | 39 |
Abandoned Applications | 75 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7436444
[patent_doc_number] => 20040266877
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Liquid pharmaceutical compositions comprising thyroid hormones'
[patent_app_type] => new
[patent_app_number] => 10/802659
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2736
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266877.pdf
[firstpage_image] =>[orig_patent_app_number] => 10802659
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/802659 | Liquid pharmaceutical compositions comprising thyroid hormones | Mar 14, 2004 | Abandoned |
Array
(
[id] => 7297587
[patent_doc_number] => 20040214861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-28
[patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine'
[patent_app_type] => new
[patent_app_number] => 10/794041
[patent_app_country] => US
[patent_app_date] => 2004-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20608
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20040214861.pdf
[firstpage_image] =>[orig_patent_app_number] => 10794041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/794041 | Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine | Mar 4, 2004 | Abandoned |
Array
(
[id] => 464460
[patent_doc_number] => 07238814
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Compositions of S-nitrosothiols and methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/781705
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17186
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781705 | Compositions of S-nitrosothiols and methods of use | Feb 19, 2004 | Issued |
Array
(
[id] => 7427034
[patent_doc_number] => 20040229854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Immediate release dosage form for HRT'
[patent_app_type] => new
[patent_app_number] => 10/781493
[patent_app_country] => US
[patent_app_date] => 2004-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4829
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20040229854.pdf
[firstpage_image] =>[orig_patent_app_number] => 10781493
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/781493 | Immediate release dosage form for HRT | Feb 17, 2004 | Abandoned |
Array
(
[id] => 7151030
[patent_doc_number] => 20040171598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Use of steroids to treat persons suffering from ocular disorders'
[patent_app_type] => new
[patent_app_number] => 10/771829
[patent_app_country] => US
[patent_app_date] => 2004-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2904
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10771829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/771829 | Use of steroids to treat persons suffering from ocular disorders | Feb 3, 2004 | Abandoned |
Array
(
[id] => 7424329
[patent_doc_number] => 20040208844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-21
[patent_title] => 'Products and drug delivery vehicles'
[patent_app_type] => new
[patent_app_number] => 10/485023
[patent_app_country] => US
[patent_app_date] => 2004-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9757
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20040208844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485023
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485023 | Products and drug delivery vehicles | Jan 27, 2004 | Abandoned |
Array
(
[id] => 7336883
[patent_doc_number] => 20040132688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C'
[patent_app_type] => new
[patent_app_number] => 10/739962
[patent_app_country] => US
[patent_app_date] => 2003-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17058
[patent_no_of_claims] => 90
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132688.pdf
[firstpage_image] =>[orig_patent_app_number] => 10739962
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/739962 | Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C | Dec 16, 2003 | Abandoned |
Array
(
[id] => 7097179
[patent_doc_number] => 20050129637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Pigment dispersion for cosmetics, cosmetic compositions containing the same, and process for making such cosmetic compositions'
[patent_app_type] => utility
[patent_app_number] => 10/735670
[patent_app_country] => US
[patent_app_date] => 2003-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3964
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129637.pdf
[firstpage_image] =>[orig_patent_app_number] => 10735670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/735670 | Pigment dispersion for cosmetics, cosmetic compositions containing the same, and process for making such cosmetic compositions | Dec 15, 2003 | Abandoned |
Array
(
[id] => 7677201
[patent_doc_number] => 20040152625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Method for improving the pharmacokinetics of an NNRTI'
[patent_app_type] => new
[patent_app_number] => 10/736301
[patent_app_country] => US
[patent_app_date] => 2003-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4160
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10736301
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/736301 | Method for improving the pharmacokinetics of an NNRTI | Dec 14, 2003 | Abandoned |
Array
(
[id] => 7070094
[patent_doc_number] => 20050245479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-03
[patent_title] => 'Myeloglycan'
[patent_app_type] => utility
[patent_app_number] => 10/726517
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 9793
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20050245479.pdf
[firstpage_image] =>[orig_patent_app_number] => 10726517
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/726517 | Myeloglycan | Dec 3, 2003 | Abandoned |
Array
(
[id] => 7326139
[patent_doc_number] => 20040138464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => '2-Oxadiazolechromone derivatives'
[patent_app_type] => new
[patent_app_number] => 10/725346
[patent_app_country] => US
[patent_app_date] => 2003-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14622
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20040138464.pdf
[firstpage_image] =>[orig_patent_app_number] => 10725346
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/725346 | 2-oxadiazolechromone derivatives | Dec 1, 2003 | Issued |
Array
(
[id] => 7238523
[patent_doc_number] => 20040157802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Anti-microbial agents derived from methionine sulfoximine analogues'
[patent_app_type] => new
[patent_app_number] => 10/715679
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9967
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157802.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715679
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715679 | Anti-microbial agents derived from methionine sulfoximine analogues | Nov 16, 2003 | Abandoned |
Array
(
[id] => 7157118
[patent_doc_number] => 20050027116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Solid phase synthesis'
[patent_app_type] => utility
[patent_app_number] => 10/685331
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5208
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20050027116.pdf
[firstpage_image] =>[orig_patent_app_number] => 10685331
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/685331 | Solid phase synthesis | Oct 13, 2003 | Abandoned |
Array
(
[id] => 7223963
[patent_doc_number] => 20050261207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-24
[patent_title] => 'Glucose-based compounds with affinity to p-selectin'
[patent_app_type] => utility
[patent_app_number] => 10/530601
[patent_app_country] => US
[patent_app_date] => 2003-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6486
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20050261207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530601 | Glucose-based compounds with affinity to P-selectin | Oct 12, 2003 | Issued |
Array
(
[id] => 7281286
[patent_doc_number] => 20040063663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Acylated cyclodextrin: guest molecule inclusion complexes'
[patent_app_type] => new
[patent_app_number] => 10/675900
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12666
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675900
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675900 | Acylated cyclodextrin: guest molecule inclusion complexes | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7674688
[patent_doc_number] => 20040127430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Chiral monophosphorus compounds and their transition metal complexes'
[patent_app_type] => new
[patent_app_number] => 10/660150
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6950
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127430.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660150 | Chiral monophosphorus compounds and their transition metal complexes | Sep 10, 2003 | Abandoned |
Array
(
[id] => 7306473
[patent_doc_number] => 20040116501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/654365
[patent_app_country] => US
[patent_app_date] => 2003-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4857
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116501.pdf
[firstpage_image] =>[orig_patent_app_number] => 10654365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/654365 | Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors | Sep 2, 2003 | Abandoned |
Array
(
[id] => 6739831
[patent_doc_number] => 20030157200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Use of oligosaccharides to stimulate beta-endorphin production'
[patent_app_type] => new
[patent_app_number] => 10/332136
[patent_app_country] => US
[patent_app_date] => 2003-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4107
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157200.pdf
[firstpage_image] =>[orig_patent_app_number] => 10332136
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/332136 | Use of oligosaccharides to stimulate beta-endorphin production | Jan 5, 2003 | Abandoned |
Array
(
[id] => 6797518
[patent_doc_number] => 20030176392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Treatment of EBV and KHSV infection and associated abnormal cellular proliferation'
[patent_app_type] => new
[patent_app_number] => 10/326444
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 42546
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176392.pdf
[firstpage_image] =>[orig_patent_app_number] => 10326444
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/326444 | Treatment of EBV and KHSV infection | Dec 18, 2002 | Issued |
Array
(
[id] => 7097172
[patent_doc_number] => 20050129630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection'
[patent_app_type] => utility
[patent_app_number] => 10/488426
[patent_app_country] => US
[patent_app_date] => 2002-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 6111
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20050129630.pdf
[firstpage_image] =>[orig_patent_app_number] => 10488426
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488426 | Utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection | Sep 2, 2002 | Abandoned |